Canopy Growth Corp (NASDAQ:CGC) shares are up on Thursday following President Donald Trump’s recent executive order urging the Department of Justice to reschedule cannabis to Schedule 3. Here’s what investors need to know.
The Game-Changer That Could Transform Cannabis Economics
This move is seen as a significant shift in federal cannabis policy, potentially impacting the entire cannabis sector as it seeks to alleviate burdensome tax regulations, which is contributing to the stock’s positive momentum while broader markets are also experiencing gains.
The executive order is hailed as the “most consequential federal cannabis policy shift” in over 50 years, with portfolio manager Dan Ahrens stating it could dismantle the crippling tax regime that has hindered U.S. cannabis operators.
Currently, cannabis companies are taxed under a federal designation reserved for illegal drug enterprises, but moving cannabis to Schedule 3 would allow them to deduct standard operating costs, significantly improving their financial outlook.
Despite the positive news, Ahrens cautions that the cannabis sector remains highly volatile, with ongoing challenges such as restrictions on U.S. cannabis companies listing on major exchanges such as NASDAQ or the New York Stock Exchange.
He notes that while a market “pop” is expected upon the finalization of rescheduling, this is just the first step in a complex process that will require further regulatory clarity.
Canopy Growth’s Struggles: A Stock In Decline
Canopy Growth is currently trading 3.7% below its 20-day simple moving average (SMA) and 10.3% below its 100-day SMA, indicating some short-term weakness despite the recent uptick. Over the past 12 months, shares have decreased by approximately 47.31%, and they are positioned closer to their 52-week lows than highs, reflecting ongoing challenges in the stock’s performance.
The RSI is at 42.58, which is considered neutral territory, suggesting that the stock is neither overbought nor oversold at this time. Meanwhile, the MACD is below its signal line, indicating bearish pressure on the stock.
The combination of neutral RSI and bearish MACD suggests mixed momentum, indicating that while there is some upward movement, the overall trend remains uncertain.
Earnings Shift: From Red To Recovery?
Investors are looking ahead to the company’s next earnings report on Feb. 6, with analysts expecting earnings per share of a loss of three cents, down from a loss of 79 cents in the same quarter last year. The revenue estimate stands at $50.59 million, down from $61.67 million in the prior year.
CGC Gains Thursday Afternoon
CGC Price Action: Canopy Growth shares closed Thursday up 2.63% at $1.17, according to Benzinga Pro data.
Image: Shutterstock
